Information Journal Paper
APA:
Copy. (2017). Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety. EXPERT OPINION ON BIOLOGICAL THERAPY, 17(-), 375-385. SID. https://sid.ir/paper/771626/en
Vancouver:
Copy. Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety. EXPERT OPINION ON BIOLOGICAL THERAPY[Internet]. 2017;17(-):375-385. Available from: https://sid.ir/paper/771626/en
IEEE:
Copy, “Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety,” EXPERT OPINION ON BIOLOGICAL THERAPY, vol. 17, no. -, pp. 375–385, 2017, [Online]. Available: https://sid.ir/paper/771626/en